Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
Recruiting
N/A
Interventional Study
Transplant;Failure,Kidney
Transplant; Failure, Liver
Adherence, Medication
Adherence, Patient
Adherence, Treatment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 13 – 25
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 65 (estimated)
- Sponsor
- Johns Hopkins University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Can the investigators create an effective way to improve adherence to immunosuppressant medication and reduce rejection, graft loss, and death in adolescents and young adults who have undergone kidney or liver transplantation? The investigators' mobile technology intervention uses real-time electronic pillbox-assessed dose timing and text message prompts to address antirejection medication nonadhe…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adolescents and young adults (13-25 years old) who underwent kidney or liver transplantation at least 6 months prior to enrollment
* Currently prescribed tacrolimus or sirolimus.
Exclusion Criteria:
* Currently receiving dialysis
* Hospitalized for duration of study
* Signif…
Contacts